Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Bhushan M. Kapur, Janine R. Hutson, Tamanna Chibber, Adriana Luk & Peter Selby. (2011) Methadone: a review of drug-drug and pathophysiological interactions. Critical Reviews in Clinical Laboratory Sciences 48:4, pages 171-195.
Read now
Read now
Michael Soyka, Henry R. Kranzler, Wim van den Brink, John Krystal, Hans-Jürgen Möller & Siegfried Kasper. (2011) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence. The World Journal of Biological Psychiatry 12:3, pages 160-187.
Read now
Read now
Thomas Kosten, Mehmet Sofuoglu, James Poling, Kishor Gonsai, Alison Oliveto, Thomas Kosten, Mehmet Sofuoglu, James Poling, Kishor Gonsai & Alison Oliveto. (2005) Desipramine Treatment for Cocaine Dependence in Buprenorphine- or Methadone-treated Patients: Baseline Urine Results as Predictor of Response. American Journal on Addictions 14:1, pages 8-17.
Read now
Read now
Thomas Kosten, Jean Falcioni, Alison Oliveto & Alan Feingold. (2004) Depression Predicts Higher Rates of Heroin Use on Desipramine with Buprenorphine than with Methadone. American Journal on Addictions 13:2, pages 191-201.
Read now
Read now
Gerardo Gonzalez, Alan Feingold, Alison Oliveto, Kishor Gonsai & Thomas R. Kosten. (2003) Comorbid Major Depressive Disorder as a Prognostic Factor in Cocaine‐Abusing Buprenorphine‐Maintained Patients Treated with Desipramine and Contingency Management. The American Journal of Drug and Alcohol Abuse 29:3, pages 497-514.
Read now
Read now
Arthur Margolin, S.
Kelly Avants, Bruce Rounsaville, ThomasR. Kosten & RichardS. Schottenfeld. (1997) Motivational Factors in Cocaine Pharmacotherapy Trials with Methadone-Maintained Patients: Problems and Paradoxes. Journal of Psychoactive Drugs 29:2, pages 205-212.
Read now
Read now
EdwardV. Nunes, StephenJ. Donovan, Ronald Brady & FredericM. Quitkin. (1994) Evaluation and Treatment of Mood and Anxiety Disorders in Opioid-Dependent Patientst. Journal of Psychoactive Drugs 26:2, pages 147-153.
Read now
Read now
DouglasM. Ziedonis & ThomasR. Kosten. (1991) Pharmacotherapy Improves Treatment Outcome in Depressed Cocaine Addicts. Journal of Psychoactive Drugs 23:4, pages 417-425.
Read now
Read now
Articles from other publishers (15)
Ahmed N. Hassan, Aaron S. Howe, Andriy V. Samokhvalov, Bernard Le Foll & Tony P. George. (2017) Management of mood and anxiety disorders in patients receiving opioid agonist therapy: Review and meta-analysis. The American Journal on Addictions 26:6, pages 551-563.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
865
880
.
Edle Ravndal & Grethe Lauritzen. (2017) Rusmisbruk, angst og depresjon etter 10 år: En prospektiv undersøkelse av stoffmisbrukere med og uten LAR-behandling. Nordic Studies on Alcohol and Drugs 32:5, pages 495-508.
Crossref
Crossref
Paola Pedrelli, Nadia Iovieno, Mario Vitali, Enrico Tedeschini, Kate H. Bentley & George I. Papakostas. (2011) Treatment of Major Depressive Disorder and Dysthymic Disorder With Antidepressants in Patients With Comorbid Opiate Use Disorders Enrolled in Methadone Maintenance Therapy. Journal of Clinical Psychopharmacology 31:5, pages 582-586.
Crossref
Crossref
Pier Paolo Pani, Rosangela Vacca, Emanuela Trogu, Laura Amato & Marina Davoli. (2010) Pharmacological treatment for depression during opioid agonist treatment for opioid dependence. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Melina Fatséas, Cécile Denis, Estelle Lavie & Marc Auriacombe. (2010) Relationship between anxiety disorders and opiate dependence— A systematic review of the literature. Journal of Substance Abuse Treatment 38:3, pages 220-230.
Crossref
Crossref
Pier Paolo Pani, Rosangela Vacca, Emanuela Trogu, Laura Amato & Marina Davoli. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Douglas J. Weschules, Kevin T. Bain & Steven Richeimer. (2008) Actual and Potential Drug Interactions Associated with Methadone. Pain Medicine 9:3, pages 315-344.
Crossref
Crossref
Edward V. Nunes, Maria A. Sullivan & Frances R. Levin. (2004) Treatment of depression in patients with opiate dependence. Biological Psychiatry 56:10, pages 793-802.
Crossref
Crossref
Stephen A Bernard. (2002) The interaction of medications used in palliative care. Hematology/Oncology Clinics of North America 16:3, pages 641-655.
Crossref
Crossref
Michael Gossop, John Marsden, Duncan Stewart & Tara Kidd. (2002) Changes in use of crack cocaine after drug misuse treatment: 4–5 year follow-up results from the National Treatment Outcome Research Study (NTORS). Drug and Alcohol Dependence 66:1, pages 21-28.
Crossref
Crossref
Stephen A. BernardEduardo Bruera. (2000) Drug Interactions in Palliative Care. Journal of Clinical Oncology 18:8, pages 1780-1799.
Crossref
Crossref
Steven P. Hamilton, Edward V. Nunes, Malvin Janal & Laurie Weber. (2010) The Effect of Sertraline on Methadone Plasma Levels in Methadone‐Maintenance Patients. The American Journal on Addictions 9:1, pages 63-69.
Crossref
Crossref
David J. R. Foster, Andrew A. Somogyi & Felix Bochner. (1999)
Methadone
N
-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4
. British Journal of Clinical Pharmacology 47:4, pages 403-412.
Crossref
Crossref
D. Wu, SV Otton, BA Sproule, U. Busto, T. Inaba, W. Kalow & EM Sellers. (2012) Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadone.. British Journal of Clinical Pharmacology 35:1, pages 30-34.
Crossref
Crossref